Skip to Main Content

Paper Details

JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Blood Adv
0
2023
JAK, JAK2, JAK2 V617F, JAK2 region, JAK2V617, JAK2V617F, JAK2V617F mutation, MF, NRM, PET-MF, PMF, PPV-MF, V617F, blood sample, hematopoietic cell, mCAs, mutation, myelofibrosis, patients, primary, primary MF, primary and secondary, single nucleotide polymorphism
Author NameAffiliation
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Mitchell J MachielaNational Cancer Institute, National Institutes of Health
Mitchell J MachielaNational Cancer Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2